ESTA vs. IRTC, PRCT, NVST, TMDX, SLNO, LIVN, ENOV, NVCR, WRBY, and LMAT
Should you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), Warby Parker (WRBY), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry.
Establishment Labs vs.
Establishment Labs (NASDAQ:ESTA) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.
Establishment Labs currently has a consensus target price of $57.40, indicating a potential upside of 38.11%. iRhythm Technologies has a consensus target price of $119.73, indicating a potential upside of 12.31%. Given Establishment Labs' higher possible upside, equities research analysts plainly believe Establishment Labs is more favorable than iRhythm Technologies.
Establishment Labs has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500.
In the previous week, Establishment Labs had 3 more articles in the media than iRhythm Technologies. MarketBeat recorded 6 mentions for Establishment Labs and 3 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.42 beat Establishment Labs' score of 1.10 indicating that iRhythm Technologies is being referred to more favorably in the news media.
Establishment Labs has higher earnings, but lower revenue than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.
72.9% of Establishment Labs shares are held by institutional investors. 11.4% of Establishment Labs shares are held by company insiders. Comparatively, 0.7% of iRhythm Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
iRhythm Technologies has a net margin of -19.14% compared to Establishment Labs' net margin of -46.13%. iRhythm Technologies' return on equity of -118.83% beat Establishment Labs' return on equity.
iRhythm Technologies received 290 more outperform votes than Establishment Labs when rated by MarketBeat users. Likewise, 66.07% of users gave iRhythm Technologies an outperform vote while only 62.30% of users gave Establishment Labs an outperform vote.
Summary
iRhythm Technologies beats Establishment Labs on 10 of the 18 factors compared between the two stocks.
Get Establishment Labs News Delivered to You Automatically
Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Establishment Labs Competitors List
Related Companies and Tools
This page (NASDAQ:ESTA) was last updated on 3/26/2025 by MarketBeat.com Staff
Buy ESTA Stock Free ESTA Stock Alerts